Skip to Main Content

Author Details

Caitlin E Mills
2007
23
13
PMIDPaper TitleJournal TitlePublished Year
37542042Proteomic profiling across breast cancer cell lines and models.Sci Data2023
37602225Paired evaluation of machine-learning models characterizes effects of confounders and outliers.Patterns (N Y)2023
37602216Erratum: Paired evaluation of machine-learning models characterizes effects of confounders and outliers.Patterns (N Y)2023
36634707Targeting TBK1 to overcome resistance to cancer immunotherapy.Nature2023
35292783Temporal and spatial topography of cell proliferation in cancer.Nature Cell Biology2022
36376301Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop.Nat Commun2022
36207580A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.Commun Biol2022
35737447Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes.Elife2022
33514515Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in <i>TP53-</i> and <i>BRCA1</i>-Deficient Cells.Cancer Res2021
32572264A single-cell landscape of high-grade serous ovarian cancer.Nat Med2020
31735695Development and Characterization of a Wee1 Kinase Degrader.Cell Chem Biol2020
32415712Development of CDK2 and CDK5 Dual Degrader TMX-2172.Angew Chem Int Ed Engl2020
31882401Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity.Cancer Research2020
31812693Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells.Cell Syst2020
32755567Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.Cell Chem Biol2020
30905681Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype.Cell Chem Biol2019
31302153A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines.Cell Syst2019
31178407Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.Cell Chem Biol2019
29199020The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.Cell Syst2018
25536231The relative biological effectiveness of low-dose mammography quality X rays in the human breast MCF-10A cell line.Radiat Res2015
21625212Evidence for the transmission of neoplastic properties from transformed to normal human stem cells.Oncogene2011
21431084Human Health and the Biological Effects of Tritium in Drinking Water: Prudent Policy Through Science - Addressing the ODWAC New Recommendation.Dose-Response2011
17441240A 4 x 500 mm2 cloverleaf detector system for in vivo bone lead measurement.Medical Physics2007
  • 1 - 23 of 23

Recommended Authors

Collaborators

Co-authored papers 19
Co-authored papers 8
Co-authored papers 7
Harvard Medical School
Co-authored papers 6
Harvard Medical School
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Co-authored papers 3
Clemson University.
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 3
Co-authored papers 3
Oregon Health Sciences University
Co-authored papers 3
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
National Center for Advancing Translational Science, 9800 Medical Center Drive
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Institute for Data Science and Computing, University of Miami
Co-authored papers 2
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Texas Southwestern Medical Center
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2